Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
0(0%)
Results Posted
23%(3 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_1
5
24%
Ph phase_4
1
5%
Ph phase_3
6
29%
Ph not_applicable
5
24%
Ph phase_2
3
14%

Phase Distribution

5

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
5(25.0%)
Phase 2Efficacy & side effects
3(15.0%)
Phase 3Large-scale testing
6(30.0%)
Phase 4Post-market surveillance
1(5.0%)
N/ANon-phased studies
5(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

13 of 15 finished

Non-Completion Rate

13.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

21

all time

Status Distribution
Active(1)
Completed(13)
Terminated(2)
Other(5)

Detailed Status

Completed13
unknown5
Withdrawn1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
0
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (25.0%)
Phase 23 (15.0%)
Phase 36 (30.0%)
Phase 41 (5.0%)
N/A5 (25.0%)

Trials by Status

completed1362%
unknown524%
withdrawn15%
not_yet_recruiting15%
terminated15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT06349122Phase 3

AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth

Not Yet Recruiting
NCT07535424Not Applicable

Comparative Efficacy of Topical Clotrimazole Versus 2% Salicylic Acid in Otomycosis

Completed
NCT00061282Phase 1

Clotrimazole Enemas for Pouchitis in Children and Adults

Terminated
NCT00000676Phase 3

Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)

Completed
NCT03005353Phase 2

Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.

Completed
NCT04292704Not Applicable

A Protocol for the Role of Fractional CO2 Laser in Consolidation Treatment of Recurrent Vulvovaginal Candidiasis

Unknown
NCT03115073Phase 2

ProF-001_Phase IIa

Completed
NCT03024502Phase 1

Patients With Vulvovaginal Candidiasis

Unknown
NCT03632733Phase 2

Effects of Antimicrobials on the Altered Skin Flora in Arsenical Keratosis

Unknown
NCT00078559Phase 1

Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

Completed
NCT02847286Phase 1

To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)

Completed
NCT01993823Phase 3

Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis

Completed
NCT02713139Phase 3

Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.

Withdrawn
NCT01547221Not Applicable

Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients

Completed
NCT00004492Phase 1

Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia

Completed
NCT02248506Phase 4

Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis

Completed
NCT00004404Not Applicable

Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes

Completed
NCT01049633

B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

Unknown
NCT00390780Phase 3

Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients

Completed
NCT01105013Phase 3

Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
21